A multicentre, randomized study to evaluate the safety and efficacy of histamine dihydrochloride and interferon-alpha-2b for the treatment of chronic hepatitis C

Interferon- (IFN-)alpha is currently the standard of care treatment for patients with chronic hepatitis C virus (HCV) infection. A significant part of the benefit of IFN-alpha in chronic hepatitis C is believed to be related to the activation of lymphocytes such as T cells and natural killer (NK) ce...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of viral hepatitis 2002-09, Vol.9 (5), p.346-353
Hauptverfasser:	Lurie, Y, Nevens, F, Aprosina, Z G, Fedorova, T A, Kalinin, A V, Klimova, E A, Ilan, Y, Maevskaya, M V, Warnes, T W, Yuschuk, N D, Hellstrand, K, Gehlsen, K R
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antiviral Agents - adverse effects Antiviral Agents - therapeutic use Drug Administration Schedule Drug Therapy, Combination Female Hepacivirus - genetics Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - genetics Hepatitis C, Chronic - physiopathology Histamine - administration & dosage Histamine - adverse effects Histamine - therapeutic use Humans Interferon-alpha - administration & dosage Interferon-alpha - adverse effects Interferon-alpha - therapeutic use Male Recombinant Proteins Treatment Outcome Viral Load
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!